fibrinogen concentrate/thrombin; fibrin sealant (Raplixa)
Jump to navigation
Jump to search
Indications
Dosage
Adverse effects
- constipation
- fever
- hypotension
- nausea
- surgical pain
Mechanism of action
- contains fibrinogen & thrombin
- promotes clotting when dissolved in blood.
More general terms
Additional terms
Components
References
- ↑ FDA News Release. April 30, 2015 FDA approves Raplixa to help control bleeding during surgery. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm445247.htm